Dr. Kim Chi Named a Highly Cited Researcher in 2025

Dr. Kim Chi, medical oncologist and clinician-scientist with BC Cancer, has been named a highly cited researcher in 2025 by Clarivate, a global organization that analyzes academic publications, citations and research impact.

“This recognition reflects my career-long commitment to improving care for people with prostate cancer,” says Dr. Kim Chi, medical oncologist, BC Cancer. “Our research has always been driven by the needs of patients, and this honour highlights the collective efforts of our collaborators, co-investigators and dedicated staff who make this work possible.”

Recipients of 2025 BC Cancer Emerging Multidisciplinary Research Programs Announced

BC Cancer’s 2025 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.

2025 Emerging Multidisciplinary Research Programs Recipients: 

BC Cancer researchers receive UBC Faculty of Medicine Distinguished Achievement Awards

Each year, the UBC Faculty of Medicine (FoM) recognizes faculty members who have made exceptional contributions in the areas of education, research and/or service, and who are dedicated to advancing both the Faculty’s values and vision of transforming health for everyone.

Two BC Cancer researchers are recipients of the 2025 UBC FoM Distinguished Achievement Awards in the following categories: 

Natural Language Processing can reduce workload, increase timeliness and improve quality of breast cancer care

A new BC Cancer project has been shown to expedite the triaging of breast cancers and accelerate the initiation of treatment. 

The CAN-TRI-NLP, or a “CANcer TRIage system to expedite care with Natural Language Processing” project, was funded through the Ministry of Health's Innovation Pathway Program to explore a new expedited breast cancer triage system for faster initiation of appropriate treatment, chemotherapy or surgery.

Back to top